Brock Summers
Psychiatry · Glendale, CANPI 1457492555
Payments from drug & device makers
Across 488 payments — averaging $4233.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$1.3M
- Supernus Pharmaceuticals, Inc.$251K
- Genentech, Inc.$145K
- Sunovion Pharmaceuticals Inc.$88K
- Merck$78K
- Purdue Pharma L.p.$48K
- plus $165K from 22 others
Across 24 payments — averaging $148.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Supernus Pharmaceuticals, Inc.$2K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 14 | $1,289,784 |
| Supernus Pharmaceuticals, Inc. | 50 | $251,249 |
| Genentech, Inc. | 31 | $145,347 |
| Sunovion Pharmaceuticals Inc. | 49 | $88,054 |
| Merck | 31 | $78,440 |
| Purdue Pharma L.p. | 11 | $48,258 |
| Biogen | 2 | $44,734 |
| Janssen Research & Development, LLC | 7 | $39,568 |
| Adlon Therapeutics L.p. | 4 | $27,382 |
| AbbVie(2 entities) | 45 | $24,966 |
| Sage Therapeutics, LLC | 4 | $9,500 |
| Jazz Pharmaceuticals Inc. | 3 | $7,500 |
| Novo Nordisk AS | 6 | $6,222 |
| Takeda Pharmaceuticals U.S.A., Inc. | 87 | $1,871 |
| Otsuka America Pharmaceutical, Inc. | 39 | $761 |
| Lundbeck LLC | 27 | $656 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 27 | $620 |
| Alkermes, Inc. | 18 | $442 |
| Johnson & Johnson | 11 | $259 |
| Vanda Pharmaceuticals Inc. | 10 | $247 |
| Axsome Therapeutics, Inc. | 3 | $94 |
| Avanir Pharmaceuticals, Inc. | 2 | $50 |
| Eisai Inc. | 2 | $38 |
| Livanova USA, Inc. | 1 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $32 |
| Noven Therapeutics, LLC | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Neuronetics, Inc. | 1 | $4 |
How this compares
$2,066,158 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Glendale
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.